We are live on ! Find out more
LCM

Lynwood Capital Management Portfolio holdings

AUM $16.9M
1-Year Est. Return 19.31%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
-19.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$83.1M
AUM Growth
-$8.46M
Cap. Flow
-$7.26M
Cap. Flow %
-8.73%
Top 10 Hldgs %
36.24%
Holding
169
New
23
Increased
9
Reduced
18
Closed
38

Sector Composition

Rank Sector Weight
1 Financials 44.44%
2 Healthcare 15.83%
3 Industrials 10.35%
4 Technology 7.08%
5 Materials 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
51
Verizon
VZ
$195B
$591K 0.71%
+15,000
New +$565K
JUN
52
DELISTED
Juniper II Corp.
JUN
$586K 0.71%
57,546
TGVC
53
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$562K 0.68%
55,362
IBER
54
DELISTED
Ibere Pharmaceuticals
IBER
$519K 0.62%
51,400
APCA
55
DELISTED
AP Acquisition Corp
APCA
$516K 0.62%
50,000
-20,000
-29% -$205K
SZZL
56
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$512K 0.62%
50,001
+25,000
+100% +$254K
STET
57
DELISTED
ST Energy Transition I Ltd.
STET
$512K 0.62%
50,068
FGMC
58
DELISTED
FG Merger Corp. Common Stock
FGMC
$510K 0.61%
50,000
MCAA
59
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$468K 0.56%
45,000
-45,000
-50% -$464K
MNST icon
60
Monster Beverage
MNST
$89.6B
$457K 0.55%
+18,000
New +$436K
ELVT
61
DELISTED
Elevate Credit, Inc.
ELVT
$405K 0.49%
+231,254
New +$321K
CANO
62
DELISTED
Cano Health, Inc.
CANO
$343K 0.41%
+2,500
New +$846K
APXI
63
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$338K 0.41%
32,800
-42,200
-56% -$431K
IQMD
64
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$324K 0.39%
31,454
MNTN
65
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$319K 0.38%
31,122
HAIA
66
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
$308K 0.37%
30,000
-11,493
-28% -$117K
BCSA
67
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$308K 0.37%
30,042
ROCL
68
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$307K 0.37%
30,361
LOKM
69
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$302K 0.36%
30,000
VZLA
70
Vizsla Silver
VZLA
$1.36B
$285K 0.34%
+250,000
New +$288K
TVGN icon
71
Tevogen Inc. Common Stock
TVGN
$27M
$268K 0.32%
518
EDSA icon
72
Edesa Biotech
EDSA
$50.5M
$264K 0.32%
+17,406
New +$130K
APN
73
DELISTED
Apeiron Capital Investment Corp
APN
$258K 0.31%
25,050
LFAC
74
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$257K 0.31%
25,000
FRXB
75
DELISTED
Forest Road Acquisition Corp. II
FRXB
$256K 0.31%
25,453

Similar funds

Lynwood Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Lynwood Capital Management held 169 positions worth $83.1M, down 9.2% from $91.6M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Lynwood Capital Management withdrew a net $7.26M in Q4 2022, closing 38 positions and reducing 18 holdings. Its most notable exit was VanEck Junior Gold Miners ETF, an estimated $2.95M position sold in full.

By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 48% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lynwood Capital Management opened a new position in X4 Pharmaceuticals worth $2.14M.

  • Lynwood Capital Management's largest Q4 2022 buy was X4 Pharmaceuticals: 71,837 shares worth $2.14M.
  • Lynwood Capital Management added most to Briacell Therapeutics in Q4 2022, an estimated $1.87M increase.
  • Lynwood Capital Management's biggest Q4 2022 reduction was Mountain & Co. I Acquisition Corp. Class A Ordinary Shares, cutting an estimated $464K.
  • Lynwood Capital Management fully exited VanEck Junior Gold Miners ETF in Q4 2022, selling an estimated $2.95M.
  • Lynwood Capital Management's ten largest holdings make up 36% of its $83.1M portfolio in Q4 2022.
  • Lynwood Capital Management opened 23 new positions and closed 38 in Q4 2022.
  • Lynwood Capital Management's portfolio value fell 9.2% quarter-over-quarter to $83.1M.

Based on Lynwood Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.